Effect of ganciclovir eye-drops for corneal endothelitis caused by cytomegalovirus infection

JRCT ID: jRCTs021180030

Registered date:25/03/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Cytomegalovirus coreal endotheliitis
• Date of first enrollment: 31/03/2016
• Target sample size: 100
• Study type: Interventional
• Intervention(s): 0.5% Ganciclovir eye-drops (4-6 times/day)

Outcome(s)

• Primary Outcome: Corneal condition
• Secondary Outcome: Intraocular pressure, Corneal endothelial cells

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Cytomegalovirus coreal endotheliitis established by the Japan Corneal Endotheliitis Study Group which was authorised by the Japanese Ministry of Health, Labour and Welfare
• Exclude criteria: Patients which did not agree to join this clinical trial

Related Information

• Primary Sponsor: Tando Toshio
• Secondary Sponsor: Mitsuru Nakazawa,